3 June 2019 in Nature Communications
The fast development of single-particle cryogenic electron microscopy (cryo-EM) has made it more feasible to obtain the 3D structure of well-behaved macromolecules with a molecular weight higher than 300 kDa at ~3 Å resolution. However, it remains a challenge to obtain the high-resolution structures of molecules smaller than 200 kDa using single-particle cryo-EM. In this work, we apply the Cs-corrector-VPP-coupled cryo-EM to study the 52 kDa streptavidin (SA) protein supported on a thin layer of graphene and embedded in vitreous ice. We are able to solve both the apo-SA and biotin-bound SA structures at near-atomic resolution using single-particle cryo-EM. We demonstrate that the method has the potential to determine the structures of molecules as small as 39 kDa.
17 July 2020 in Proceedings of the National Academy of Sciences
Significance: Membrane proteins (MPs), encoded by ∼30% of the coding genes, play vital roles in numerous physiological processes. MPs are targets of more than half of the FDA-approved drugs. High-resolution structural studies of functional membrane proteins under near-physiological conditions are required to provide an in-depth mechanistic understanding and to facilitate drug discovery. To embed the proteins into liposomes represents a strategy to mimic native membrane conditions. Here we present a convenient workflow for cryo-EM analysis of liposome-embedded MPs using the prototypal protein AcrB. Our method sets the foundation for future investigation of MPs in the presence of electrochemical gradients and for the understanding of the interdependence of integral or peripheral MPs and various membrane properties.
3 June 2023 in Nature Communications
Voltage-gated sodium (Nav) channels are targeted by a number of widely used and investigational drugs for the treatment of epilepsy, arrhythmia, pain, and other disorders. Despite recent advances in structural elucidation of Nav channels, the binding mode of most Nav-targeting drugs remains unknown. Here we report high-resolution cryo-EM structures of human Nav1.7 treated with drugs and lead compounds with representative chemical backbones at resolutions of 2.6-3.2 Å. A binding site beneath the intracellular gate (site BIG) accommodates carbamazepine, bupivacaine, and lacosamide. Unexpectedly, a second molecule of lacosamide plugs into the selectivity filter from the central cavity. Fenestrations are popular sites for various state-dependent drugs. We show that vinpocetine, a synthetic derivative of a vinca alkaloid, and hardwickiic acid, a natural product with antinociceptive effect, bind to the III-IV fenestration, while vixotrigine, an analgesic candidate, penetrates the IV-I fenestration of the pore domain. Our results permit building a 3D structural map for known drug-binding sites on Nav channels summarized from the present and previous structures.
25 January 2023 in Proceedings of the National Academy of Sciences
Voltage-gated sodium channel Na v 1.6 plays a crucial role in neuronal firing in the central nervous system (CNS). Aberrant function of Na v 1.6 may lead to epilepsy and other neurological disorders. Specific inhibitors of Na v 1.6 thus have therapeutic potentials. Here we present the cryo-EM structure of human Na v 1.6 in the presence of auxiliary subunits β1 and fibroblast growth factor homologous factor 2B (FHF2B) at an overall resolution of 3.1 Å. The overall structure represents an inactivated state with closed pore domain (PD) and all “up” voltage-sensing domains. A conserved carbohydrate–aromatic interaction involving Trp302 and Asn326, together with the β1 subunit, stabilizes the extracellular loop in repeat I. Apart from regular lipids that are resolved in the EM map, an unprecedented Y-shaped density that belongs to an unidentified molecule binds to the PD, revealing a potential site for developing Na v 1.6-specific blockers. Structural mapping of disease-related Na v 1.6 mutations provides insights into their pathogenic mechanism.
2 October 2023 in Proceedings of the National Academy of Sciences
Voltage-gated sodium (Nav) channels govern membrane excitability, thus setting the foundation for various physiological and neuronal processes. Navchannels serve as the primary targets for several classes of widely used and investigational drugs, including local anesthetics, antiepileptic drugs, antiarrhythmics, and analgesics. In this study, we present cryogenic electron microscopy (cryo-EM) structures of human Nav1.7 bound to two clinical drugs, riluzole (RLZ) and lamotrigine (LTG), at resolutions of 2.9 Å and 2.7 Å, respectively. A 3D EM reconstruction of ligand-free Nav1.7 was also obtained at 2.1 Å resolution. RLZ resides in the central cavity of the pore domain and is coordinated by residues from repeats III and IV. Whereas one LTG molecule also binds to the central cavity, the other is found beneath the intracellular gate, known as site BIG. Therefore, LTG, similar to lacosamide and cannabidiol, blocks Navchannels via a dual-pocket mechanism. These structures, complemented with docking and mutational analyses, also explain the structure–activity relationships of the LTG-related linear 6,6 series that have been developed for improved efficacy and subtype specificity on different Navchannels. Our findings reveal the molecular basis for these drugs’ mechanism of action and will aid the development of novel antiepileptic and pain-relieving drugs.